Expertise in
29
conditions

Dr. Timothy D. Henry

Cardiology
The Christ Hospital Physicians-Heart & Vascular
2123 Auburn Ave Ste 136, 
Cincinnati, OH 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
29
conditions
The Christ Hospital Physicians-Heart & Vascular
2123 Auburn Ave Ste 136, 
Cincinnati, OH 

Overview

Timothy Henry is a Cardiologist practicing medicine in Cincinnati, Ohio.

Dr. Henry is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Heart Attack, Angina, Cardiogenic Shock, Percutaneous Coronary Intervention (PCI), and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 519 peer reviewed articles and participating in 7 clinical trials. Dr. Henry is currently accepting new patients.

Specialties

Cardiology

Licenses

Internal Medicine in MN

Hospital Affiliations

Christ Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

The Christ Hospital Physicians-Heart & Vascular
2123 Auburn Ave Ste 136, Cincinnati, OH 45219

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Human Recombinant Fibroblast Growth Factor-1 (FGF-1), for the Treatment of Subjects With Severe Coronary Heart Disease, a Placebo Controlled, Double-blind, Dose-varying Study
Human Recombinant Fibroblast Growth Factor-1 (FGF-1), for the Treatment of Subjects With Severe Coronary Heart Disease, a Placebo Controlled, Double-blind, Dose-varying Study
Enrollment Status: Not_yet_recruiting
Publish Date: August 19, 2026
Intervention Type: Combination product
Study Drug: Human Recombinant Fibroblast Growth Factor-1
Study Phase: Phase 2
Phase 1 Open Label, Dose Escalation Trial of Intracoronary Infusion of AB-1002 in Subjects With NYHA Class III Heart Failure
Phase 1 Open Label, Dose Escalation Trial of Intracoronary Infusion of AB-1002 in Subjects With NYHA Class III Heart Failure
Enrollment Status: Completed
Publish Date: August 06, 2026
Intervention Type: Biological
Study Drug: 3 x 10e13vg NAN-101
Study Phase: Phase 1
A Double-Blind, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of CLBS16 in Subjects With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease
A Double-Blind, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of CLBS16 in Subjects With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease
Enrollment Status: Terminated
Publish Date: May 04, 2026
Intervention Type: Biological
Study Drug: CLBS16 Granulocyte Colony-Stimulating Factor-Mobilized Autologous CD34-Positive Cells
Study Phase: Phase 2
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2
A Prospective, Double-Blind, Randomized, Placebo-controlled Clinical Trial of Intracoronary Infusion of Mesenchymal Precursor Cells (MPC) in the Treatment of Patients With ST-Elevation Myocardial Infarction
A Prospective, Double-Blind, Randomized, Placebo-controlled Clinical Trial of Intracoronary Infusion of Mesenchymal Precursor Cells (MPC) in the Treatment of Patients With ST-Elevation Myocardial Infarction
Enrollment Status: Completed
Publish Date: June 23, 2022
Intervention Type: Other, Biological
Study Drugs: 12.5 M Mesenchymal Precursor Cells (MPC), 25M Mesenchymal Precursor Cells (MPC)
Study Phase: Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination With Filgrastim in Early Recovery Post-Myocardial Infarction
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination With Filgrastim in Early Recovery Post-Myocardial Infarction
Enrollment Status: Completed
Publish Date: May 27, 2021
Intervention Type: Drug
Study Phase: Phase 2
An Open-Label Exploratory Clinical Study to Evaluate the Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction (CMD) and Without Obstructive Coronary Artery Disease
An Open-Label Exploratory Clinical Study to Evaluate the Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction (CMD) and Without Obstructive Coronary Artery Disease
Enrollment Status: Completed
Publish Date: January 08, 2021
Intervention Type: Biological
Study Phase: Phase 2
View 6 Less Clinical Trials

519 Total Publications

Cardiotropic Adeno-Associated Virus-Based Gene Therapy via Intracoronary Delivery for Nonischemic Heart Failure.
Cardiotropic Adeno-Associated Virus-Based Gene Therapy via Intracoronary Delivery for Nonischemic Heart Failure.
Journal: Canadian journal of physiology and pharmacology
Published: August 19, 2026
Similar Doctors
Expertise in
35
conditions
Expertise in
35
conditions
Referral may be required
Before you request

The Christ Hospital Physicians-Heart & Vascular

2123 Auburn Ave Ste 136, 
Cincinnati, OH 
 (0.1 miles away)
513-206-1060
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Dean Kereiakes is a Cardiologist practicing medicine in Cincinnati, Ohio. Dr. Kereiakes is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Aortic Valve Stenosis, Angina, Lithotripsy, and Percutaneous Coronary Intervention (PCI). Dr. Kereiakes is currently accepting new patients.

Expertise in
43
conditions
Expertise in
43
conditions
Referral may be required
Before you request

Cincinnati Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati,, OH 
 (1.1 miles away)
513-636-4432
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Alexander Opotowsky is a Cardiologist practicing medicine in Cincinnati,, Ohio. Dr. Opotowsky is highly rated in 43 conditions, according to our data. His clinical expertise encompasses Congenital Heart Disease (CHD), Coarctation of the Aorta, Transposition of the Great Arteries, Tetralogy of Fallot, and Heart Transplant. Dr. Opotowsky is currently accepting new patients.

Expertise in
38
conditions
Expertise in
38
conditions
Referral may be required
Before you request

The Christ Hospital Physicians-Heart & Vascular

2123 Auburn Ave Ste 138, 
Cincinnati, OH 
 (0.1 miles away)
513-206-1180
Languages Spoken:
English, Korean
See accepted insurances
Accepting New Patients

Eugene Chung is a Cardiologist practicing medicine in Cincinnati, Ohio. Dr. Chung is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Edema, Pacemaker Implantation, and Aortic Valve Replacement. Dr. Chung is currently accepting new patients.

Frequently Asked Questions about Dr. Timothy D. Henry

How do I make an appointment with Dr. Timothy D. Henry?

You can book an appointment with Dr. Timothy D. Henry by calling their office at 513-206-1060. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Timothy D. Henry a top-rated expert for Heart Attack?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Timothy D. Henry is classified as an Elite expert for Heart Attack, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Timothy D. Henry specialize in?

While Dr. Timothy D. Henry is a Cardiology, they have specific expertise in Heart Attack, Angina, and Percutaneous Coronary Intervention (PCI). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.

Does Dr. Timothy D. Henry participate in research or clinical trials?

Yes. Dr. Timothy D. Henry has published 519 articles and abstracts on conditions like Heart Attack. You can view a list of Dr. Timothy D. Henry's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Timothy D. Henry accept my insurance?

Dr. Timothy D. Henry accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 513-206-1060 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Henry's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 8 Distinguished Conditions
View All 14 Advanced Conditions
View All 47 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile